Posts
August 17 2016
Neonode, Inc. announced the closing of their PIPE offering in the amount of $8,600,000. EG&S acted as counsel to the Placement Agent.
August 16 2016
PFO Global, Inc. announced the closing of their PIPE offering in the amount of $448,000. EG&S acted as counsel to the Investor.
August 15 2016
Catasys, Inc. announced the closing of their PIPE offering in the amount of $1,500,000. EG&S acted as counsel to the Investor.
August 15 2016
StemCells, Inc. announced the closing of their PIPE offering in the amount of $2,000,000. EG&S acted as counsel to the Investor.
August 12 2016
ImmunoCellular Therapeutics, Ltd. announced the closing of an underwritten common stock and warrant offering in the amount of $7.5 million. EG&S acted as counsel to Maxim Group LLC, the representative of the underwriters in the offering.
August 12 2016
Boston Therapeutics, Inc. announced the closing of their PIPE offering in the amount of $1,300,000. EG&S acted as counsel to the placement agent.
August 12 2016
Aridis Pharmaceuticals, Inc. announced the closing of their private placement in the amount of $15,200,000. EG&S acted as counsel to the placement agent.
August 11 2016
Check Cap Ltd. announced the closing of their Registered Direct offering in the amount of $6,000,000. EG&S acted as counsel to the Investor.